Humbert M - Search Results

1

Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension.

Humbert M, McLaughlin V, Gibbs JSR, Gomberg-Maitland M, Hoeper MM, Preston IR, Souza R, Waxman AB, Ghofrani HA, Escribano Subias P, Feldman J, Meyer G, Montani D, Olsson KM, Manimaran S, de Oliveira Pena J, Badesch DB. Humbert M, et al. Eur Respir J. 2023 Jan 6;61(1):2201347. doi: 10.1183/13993003.01347-2022. Print 2023 Jan. Eur Respir J. 2023. PMID: 36041750 Free PMC article. Clinical Trial.

2

[Pulmonary arterial hypertension].

Montani D, Hamid A, Yaïci A, Sztrymf B, Humbert M. Montani D, et al. Among authors: humbert m. Rev Prat. 2004 Jan 15;54(1):5-13. Rev Prat. 2004. PMID: 15049592 Review. French.

3

NT-proBNP as a tool to stratify disease severity in pulmonary arterial hypertension.

Souza R, Jardim C, Julio Cesar Fernandes C, Silveira Lapa M, Rabelo R, Humbert M. Souza R, et al. Among authors: humbert m. Respir Med. 2007 Jan;101(1):69-75. doi: 10.1016/j.rmed.2006.04.014. Epub 2006 Jun 14. Respir Med. 2007. PMID: 16781131 Free article.

4

Medical therapies for chronic thromboembolic pulmonary hypertension: an evolving treatment paradigm.

Bresser P, Pepke-Zaba J, Jaïs X, Humbert M, Hoeper MM. Bresser P, et al. Among authors: humbert m. Proc Am Thorac Soc. 2006 Sep;3(7):594-600. doi: 10.1513/pats.200605-115LR. Proc Am Thorac Soc. 2006. PMID: 16963540 Review.

5

Endothelin-1/endothelin-3 ratio: a potential prognostic factor of pulmonary arterial hypertension.

Montani D, Souza R, Binkert C, Fischli W, Simonneau G, Clozel M, Humbert M. Montani D, et al. Among authors: humbert m. Chest. 2007 Jan;131(1):101-8. doi: 10.1378/chest.06-0682. Chest. 2007. PMID: 17218562

6

Intravenous epoprostenol in inoperable chronic thromboembolic pulmonary hypertension.

Cabrol S, Souza R, Jais X, Fadel E, Ali RH, Humbert M, Dartevelle P, Simonneau G, Sitbon O. Cabrol S, et al. Among authors: humbert m. J Heart Lung Transplant. 2007 Apr;26(4):357-62. doi: 10.1016/j.healun.2006.12.014. J Heart Lung Transplant. 2007. PMID: 17403477

7

Pulmonary hypertension: from an orphan disease to a public health problem.

Humbert M, Khaltaev N, Bousquet J, Souza R. Humbert M, et al. Chest. 2007 Aug;132(2):365-7. doi: 10.1378/chest.07-0903. Chest. 2007. PMID: 17699126 No abstract available.

8

Pulmonary arterial hypertension in ANCA-associated vasculitis.

Launay D, Souza R, Guillevin L, Hachulla E, Pouchot J, Simonneau G, Humbert M. Launay D, et al. Among authors: humbert m. Sarcoidosis Vasc Diffuse Lung Dis. 2006 Oct;23(3):223-8. Sarcoidosis Vasc Diffuse Lung Dis. 2006. PMID: 18038922

9

Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation.

Sztrymf B, Coulet F, Girerd B, Yaici A, Jais X, Sitbon O, Montani D, Souza R, Simonneau G, Soubrier F, Humbert M. Sztrymf B, et al. Among authors: humbert m. Am J Respir Crit Care Med. 2008 Jun 15;177(12):1377-83. doi: 10.1164/rccm.200712-1807OC. Epub 2008 Mar 20. Am J Respir Crit Care Med. 2008. PMID: 18356561

10

Safety experience with bosentan in 146 children 2-11 years old with pulmonary arterial hypertension: results from the European Postmarketing Surveillance program.

Beghetti M, Hoeper MM, Kiely DG, Carlsen J, Schwierin B, Segal ES, Humbert M. Beghetti M, et al. Among authors: humbert m. Pediatr Res. 2008 Aug;64(2):200-4. doi: 10.1203/PDR.0b013e318179954c. Pediatr Res. 2008. PMID: 18414142

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,372 results

Search Page